Protein-Protein Coupling/Uncoupling Enables Dopamine D2Receptor Regulation of AMPA Receptor-Mediated Excitotoxicity
Open Access
- 27 April 2005
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 25 (17) , 4385-4395
- https://doi.org/10.1523/jneurosci.5099-04.2005
Abstract
Here is considerable evidence that dopamine D2 receptors can modulate AMPA receptor-mediated neurotoxicity. However, the molecular mechanism underlying this process remains essentially unclear. Here we report that D2 receptors inhibit AMPA-mediated neurotoxicity through two pathways: the activation of phosphoinositide-3 kinase (PI-3K) and downregulation of AMPA receptor plasma membrane expression, both involving a series of protein-protein coupling/uncoupling events. Agonist stimulation of D2 receptors promotes the formation of the direct protein-protein interaction between the third intracellular loop of the D2 receptor and the ATPase N-ethylmaleimide-sensitive factor (NSF) while uncoupling the NSF interaction with the carboxyl tail (CT) of the glutamate receptor GluR2 subunit of AMPA receptors. Previous studies have shown that full-length NSF directly couples to the GluR2CT and facilitates AMPA receptor plasma membrane expression. Furthermore, the CT region of GluR2 subunit is also responsible for several other intracellular protein couplings, including p85 subunit of PI-3K. Therefore, the direct coupling of D2-NSF and concomitant decrease in the NSF-GluR2 interaction results in a decrease of AMPA receptor membrane expression and an increase in the interaction between GluR2 and the p85 and subsequent activation of PI-3K. Disruption of the D2-NSF interaction abolished the ability of D2 receptor to attenuate AMPA-mediated neurotoxicity by blocking the D2 activation-induced changes in PI-3K activity and AMPA receptor plasma membrane expression. Furthermore, the D2-NSF-GluR2-p85 interactions are also responsible for the D2 inhibition of ischemia-induced cell death. These data may provide a new avenue to identify specific targets for therapeutics to modulate glutamate receptor-governed diseases, such as stroke.Keywords
This publication has 84 references indexed in Scilit:
- Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTENJournal of Neuroscience, 2004
- Regulation of kainate receptors by protein kinase C and metabotropic glutamate receptorsThe Journal of Physiology, 2003
- Disruption of the GluR2-NSF Interaction Protects Primary Hippocampal Neurons from Ischemic StressMolecular and Cellular Neuroscience, 2001
- Chimeric D2/D3Dopamine Receptor Coupling to Adenylyl CyclaseBiochemical and Biophysical Research Communications, 1997
- Chimeric D2/D3 Dopamine Receptors Efficiently Inhibit Adenylyl Cyclase in HEK 293 CellsJournal of Neurochemistry, 1996
- The N-Ethylmaleimide-sensitive Fusion Protein and α-SNAP Induce a Conformational Change in SyntaxinPublished by Elsevier ,1995
- Mechanisms of intracellular protein transportNature, 1994
- Two sites in the third inner loop of the dopamine D2 receptor are involved in functional G protein‐mediated coupling to adenylate cyclaseFEBS Letters, 1993
- The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbilsBrain Research, 1988
- NEURONAL ALTERATIONS IN HIPPOCAMPUS FOLLOWING SEVERE HYPOGLYCAEMIA: A LIGHT MICROSCOPIC AND ULTRASTRUCTURAL STUDY IN THE RATNeuropathology and Applied Neurobiology, 1985